Market Cap (In USD)
4.67 Million
Revenue (In USD)
9.77 Million
Net Income (In USD)
-2.62 Million
Avg. Volume
391.6 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.231-3.39
- PE
- -
- EPS
- -
- Beta Value
- 1.866
- ISIN
- US0906282076
- CUSIP
- 090628108
- CIK
- 1737523
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Su-Leng Tan
- Employee Count
- -
- Website
- https://www.bionexusgenelab.com
- Ipo Date
- 2021-01-08
- Details
- BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
More Stocks
-
WPPWPP plc
WPP
-
ETCMY
-
WARNWarteck Invest AG
WARN
-
000498
-
IDOXIDOX plc
IDOX
-
7711
-
NLOP
-
ALMIL1000mercis
ALMIL